Stock Comparison
ABBV vs AZN
AbbVie Inc and AstraZeneca PLC side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$447.62B
$292.20B
P/E (TTM)
123.6
28.4
Forward P/E
17.8
17.9
Price/Sales
7.1
4.8
Price/Book
50.5
6.2
EV/EBITDA
30.2
15.8
Dividend Yield
2.77%
1.72%
Profitability
Net Margin
5.79%
17.20%
Operating Margin
32.20%
27.90%
Return on Equity
62.30%
23.50%
Return on Assets
10.00%
8.49%
Growth (YoY)
Revenue Growth
12.40%
12.50%
Earnings Growth
-46.20%
5.30%
Price & Risk
Beta
0.3
0.2
52-Week High
$253.35
$210.50
52-Week Low
$176.02
$134.85
Analyst Target
$254.38
$224.49
Compare ABBV and AZN your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.